Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients. Issue 1 (4th October 2020)
- Record Type:
- Journal Article
- Title:
- Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients. Issue 1 (4th October 2020)
- Main Title:
- Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients
- Authors:
- Mendelaar, Pauline A. J.
Kraan, Jaco
Van, Mai
Zeune, Leonie L.
Terstappen, Leon W. M. M.
Oomen‐de Hoop, Esther
Martens, John W. M.
Sleijfer, Stefan - Abstract:
- Abstract : Circulating tumor cells (CTCs) in the blood of cancer patients are of high clinical relevance. Since detection and isolation of CTCs often rely on cell dimensions, knowledge of their size is key. We analyzed the median CTC size in a large cohort of breast (BC), prostate (PC), colorectal (CRC), and bladder (BLC) cancer patients. Images of patient‐derived CTCs acquired on cartridges of the FDA‐cleared CellSearch ® method were retrospectively collected and automatically re‐analyzed using the accept software package. The median CTC diameter (μm) was computed per tumor type. The size differences between the different tumor types and references (tumor cell lines and leukocytes) were nonparametrically tested. A total of 1962 CellSearch ® cartridges containing 71 612 CTCs were included. In BC, the median computed diameter (CD) of patient‐derived CTCs was 12.4 μm vs 18.4 μm for cultured cell line cells. For PC, CDs were 10.3 μm for CTCs vs 20.7 μm for cultured cell line cells. CDs for CTCs of CRC and BLC were 7.5 μm and 8.6 μm, respectively. Finally, leukocytes were 9.4 μm. CTC size differed statistically significantly between the four tumor types and between CTCs and the reference data. CTC size differences between tumor types are striking and CTCs are smaller than cell line tumor cells, whose size is often used as reference when developing CTC analysis methods. Based on our data, we suggest that the size of CTCs matters and should be kept in mind when designing andAbstract : Circulating tumor cells (CTCs) in the blood of cancer patients are of high clinical relevance. Since detection and isolation of CTCs often rely on cell dimensions, knowledge of their size is key. We analyzed the median CTC size in a large cohort of breast (BC), prostate (PC), colorectal (CRC), and bladder (BLC) cancer patients. Images of patient‐derived CTCs acquired on cartridges of the FDA‐cleared CellSearch ® method were retrospectively collected and automatically re‐analyzed using the accept software package. The median CTC diameter (μm) was computed per tumor type. The size differences between the different tumor types and references (tumor cell lines and leukocytes) were nonparametrically tested. A total of 1962 CellSearch ® cartridges containing 71 612 CTCs were included. In BC, the median computed diameter (CD) of patient‐derived CTCs was 12.4 μm vs 18.4 μm for cultured cell line cells. For PC, CDs were 10.3 μm for CTCs vs 20.7 μm for cultured cell line cells. CDs for CTCs of CRC and BLC were 7.5 μm and 8.6 μm, respectively. Finally, leukocytes were 9.4 μm. CTC size differed statistically significantly between the four tumor types and between CTCs and the reference data. CTC size differences between tumor types are striking and CTCs are smaller than cell line tumor cells, whose size is often used as reference when developing CTC analysis methods. Based on our data, we suggest that the size of CTCs matters and should be kept in mind when designing and optimizing size‐based isolation methods. Abstract : Molecular characterization of circulating tumor cells is of high clinical relevance. Since circulating tumor cell (CTC) detection and isolation often rely on cell dimensions, we determined the size of 71 612 CellSearch‐detected CTCs using accept software. Strikingly, CTC size differs between tumor types and significantly deviates from the size of cultured tumor cells, which is currently used in the development of CTC isolation methods. … (more)
- Is Part Of:
- Molecular oncology. Volume 15:Issue 1(2021)
- Journal:
- Molecular oncology
- Issue:
- Volume 15:Issue 1(2021)
- Issue Display:
- Volume 15, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2021-0015-0001-0000
- Page Start:
- 116
- Page End:
- 125
- Publication Date:
- 2020-10-04
- Subjects:
- cell morphology -- cell size -- circulating tumor cells -- metastatic cancer -- single cell isolation methods
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.12802 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23865.xml